• videocam Live Webinar with Live Q&A
  • calendar_month December 3, 2026 @ 1:00 PM ET/10:00 AM PT
  • signal_cellular_alt Intermediate
  • card_travel Corporate Law
  • schedule 90 minutes

Corporate Directors and Officers: Indemnification and Advancement Issues

Drafting Agreements, Bylaws, and Liability Protections; Advancement Claims, Exculpation, and D&O Insurance

About the Course

Introduction

This CLE webinar will cover structuring and enforcing indemnification and advancement protections for corporate directors and officers. The panel will examine how charter provisions, bylaws, indemnification agreements, exculpation, and D&O insurance interact, and will explore drafting practices and the disputes that may arise when directors and officers seek advancement or indemnification.

Description

Directors and officers facing litigation, investigations, or other proceedings may incur substantial defense costs before their potential liability is determined. Whether the corporation must advance those costs and indemnify the director/officer turns on applicable corporate law and the respective rights provided in the corporation's governing documents and indemnification agreements. Corporate counsel must determine the appropriate scope of indemnification and advancement rights and ensure that the company's charter, bylaws, and indemnification agreements work together successfully.

Separate indemnification agreements can provide directors and officers with greater certainty than only relying on statutory rights and corporate bylaws. Counsel must also navigate the interaction of the documents with exculpation and D&O insurance. These protections address different risks and may not provide full coverage.

Listen as our authoritative panel discusses drafting indemnification and advancement protections and practical steps for corporate counsel should claims arise.

Presented By

Lenin E. Lopez
Senior Vice President, Executive and Financial Risk
Gallagher

Mr. Lopez has deep experience in providing legal counsel to public company boards and executive management in helping them navigate a range of legal and business matters, including corporate governance, securities law compliance, capital markets transactions, executive compensation, and other general corporate matters. Prior to joining Woodruff Sawyer, Mr. Lopez served as Lead Counsel -- SEC Reporting at Takeda Pharmaceuticals Co., a global biopharmaceutical company, where he led the U.S. corporate governance and securities function.

Stephen T. Raptis
Partner
Crowell & Moring

Mr. Raptis has represented commercial policyholders in complex insurance disputes for more than 25 years. He emphasizes strategic and creative solutions for resolving disputed claims, including focused negotiations and mediation, to maximize recoveries for clients while seeking to minimize their costs. Through thorough claim analysis and advocacy, Mr. Raptis has helped policyholder clients successfully obtain reversals of scores of adverse coverage determinations without the need for litigation. But when necessary, he aggressively litigates coverage lawsuits in state and federal courts throughout the country.

Credit Information
  • This 90-minute webinar is eligible in most states for 1.5 CLE credits.


  • Live Online


    On Demand

Date + Time

  • event

    Thursday, December 3, 2026

  • schedule

    1:00 PM ET/10:00 AM PT

I. Indemnification and advancement framework

A. Statutory rights, governing documents, and contractual protections

II. Drafting bylaws and indemnification agreements

III. Understanding and managing advancement claims

IV. Exculpation, indemnification, and D&O insurance

V. Transactions and change in control

VI. Practitioner takeaways

The panel will review these and other key issues:

  • What indemnification and advancement rights are available under corporate law?
  • How can governing documents expand or limit those rights?
  • What provisions should counsel include in bylaws and separate indemnification agreements?
  • How do exculpation, indemnification, advancement, and D&O insurance differ and interact?